Search filters

List of works by Andrea Vingiani

Analysis of Efficacy and Accuracy of 2 Vacuum-Assisted Breast Biopsy Devices: Mammotome and Elite

scientific article published on 30 June 2018

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca

scientific article published on 2 August 2017

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in I

scientific article published in September 2017

Biomarkers for the identification of recurrence in human epidermal growth factor receptor 2-positive breast cancer patients

scientific article published on 17 September 2016

Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer

scientific article published on 23 November 2015

Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series

scientific article published on 17 January 2019

Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial

scientific article published on 14 August 2015

Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer

scientific article published on 23 July 2018

Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications

scientific article published on 09 December 2020

Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients

scientific article published on 16 April 2021

Oncological Outcomes of Nipple-Sparing Mastectomy: A Single-Center Experience of 1989 Patients

scientific article published on 17 September 2018

Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy

scientific article published on 01 February 2019

Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer

scientific article published on 15 November 2017

Retroperitoneal pararenal isolated neurofibroma: report of a case and review of literature.

scientific article published on 15 May 2012

Salivary gland choristoma in large bowel

scientific article published on 06 March 2012

Solitary thyroid metastasis from colon cancer: a rare case report

scientific article published on 24 November 2016

The Stearoyl-CoA Desaturase-1 (Desat1) in Drosophila cooperated with Myc to Induce Autophagy and Growth, a Potential New Link to Tumor Survival

scientific article

The clinical relevance of micropapillary carcinoma of the breast: a case-control study

scientific article

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.

scientific article published on February 2017

Towards mm-wave spectroscopy for dielectric characterization of breast surgical margins

scientific article published on 27 February 2019

Tumor infiltrating lymphocytes in early breast cancer

scientific article published on 28 March 2017

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

scientific article published on 16 January 2019

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.

scientific article published on 02 July 2016

Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy

scientific article published on 18 February 2015

Unfavorable prognostic role of tumor-infiltrating lymphocytes in hormone-receptor positive, HER2 negative metastatic breast cancer treated with metronomic chemotherapy

scientific article published on 22 May 2017